Abstract
Japan’s Fujifilm has acquired Wako Pure Chemical Industries for $1.3 billion and is now creating a fine chemicals division to house its chemical operations. Wako, previously majority-owned by Takeda Pharmaceutical and Nihon Pharmaceutical, supplies about 200,000 lab chemicals and produces diagnostic reagents and fine chemicals used in the life sciences and electronics industries. Fujifilm says the acquisition of Wako will boost its presence in the fine chemicals and life sciences sectors, where by itself or through subsidiaries, it already provides electronic materials, cells used in regenerative medicine (see page 23), and contract manufacturing services. Fujifilm notes that it has long experience in the fine chemicals sector thanks to its roots as a producer of photographic film.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
